Company Filing History:
2 out of 67 
1 out of 1 
1 out of 13 Years Active: 2005-2011
Title: Innovations and Contributions of Johan Hendrika Jozef Vingerhoets
Introduction
Johan Hendrika Jozef Vingerhoets is a notable inventor based in Wijnegem, Belgium. He has made significant contributions to the field of nucleic acid diagnostics, particularly in relation to HIV treatment. With a total of 4 patents, his work has had a profound impact on drug development and therapeutic efficacy.
Latest Patents
One of his latest patents is titled "Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance." This invention focuses on the identification of base variation in target nucleic acid sequences, specifically in HIV. It aims to correlate virus mutational profiles with drug resistance, which is crucial for effective treatment strategies. Another significant patent is "Methods and means for assessing HIV envelope inhibitor therapy." This invention evaluates the therapeutic efficacy of drugs by analyzing molecular events at the HIV envelope protein. The methods developed can be utilized in diagnostics, drug screening, pharmacogenetics, and drug development.
Career Highlights
Throughout his career, Vingerhoets has worked with prominent companies such as Tibotec Pharmaceuticals Ltd. and Tibotech Bvba. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of HIV treatment.
Collaborations
Some of his notable coworkers include Lieve Emma Jan Michiels and Inge Dierynck. Their collaborative efforts have further advanced the research and innovations in HIV diagnostics and treatment.
Conclusion
Johan Hendrika Jozef Vingerhoets is a distinguished inventor whose work has significantly influenced the field of HIV treatment and diagnostics. His patents reflect a commitment to improving therapeutic outcomes and advancing medical research.